Dermira and UCB Agree to End Collaboration Agreement for CIMZIA
Nov 06, 2017 21:01 pm UTC| Business
Dermira to transition development and commercialization responsibility for CIMZIA® (certolizumab pegol) in psoriasis back to UCBDecision reflects both companies’ strategic prioritiesUCB remains committed to bringing CIMZIA...
Nuvectra to Present at the Stifel 2017 Healthcare Conference
Nov 06, 2017 21:01 pm UTC| Business
PLANO, Texas, Nov. 06, 2017 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer Chief...
Endocyte Reports Third Quarter Financial Results
Nov 06, 2017 21:01 pm UTC| Business
– Plans to Initiate Phase 3 Registration for 177Lu-PSMA-617 Accelerated by Radiomedix Agreement to Transfer Active U.S. Investigational New Drug Application (IND) to Endocyte – – The University of Sydney...
Gippsland Health Alliance selects Allscripts EMR
Nov 06, 2017 21:01 pm UTC| Business
MELBOURNE, Australia, Nov. 06, 2017 -- As a result of a competitive tender, Gippsland Health Alliance has selected Allscripts (NASDAQ:MDRX) to deliver an Electronic Medical Record (EMR) solution to the Gippsland Health...
Spero Therapeutics Announces Closing of Initial Public Offering
Nov 06, 2017 21:01 pm UTC| Business
CAMBRIDGE, Mass., Nov. 06, 2017 -- Spero Therapeutics, Inc., a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant...
Federated National Holding Company Reports Third Quarter 2017 Results
Nov 06, 2017 21:00 pm UTC| Business
SUNRISE, Fla., Nov. 06, 2017 -- Federated National Holding Company (the “Company”) (Nasdaq:FNHC) today reported results for the three and nine months ended September 30, 2017. Q3 2017 highlights (as measured against...
Nov 06, 2017 21:00 pm UTC| Business
SAN DIEGO, Nov. 06, 2017 -- Kratos Defense Security Solutions, Inc. (“Kratos”) (Nasdaq:KTOS), announced today that it intends to offer, subject to market and other customary conditions, $300 million aggregate principal...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update